CompletedNCT02559167
Cannabidiol for Cocaine Craving and Return to Use
About this title
Read the official source — NCT02559167Medication studyAges 18–65CanadaAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- MontrealSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: July 1, 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 79
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02559167
- Official title
Show the full official title
Cannabidiol as a New Treatment for Cocaine Addiction
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Montreal
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre hospitalier de l'Université de Montréal (CHUM), a university.
Did this study involve medication?
Yes. The study involved medication, including Cannabidiol.
Who was this study for?
Listed age limits: 18 years to 65 years.
